Testing an Experimental Coronavirus Vaccine

March 2, 2020

Testing an Experimental Coronavirus Vaccine

An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna is ready to enter human testing, announced NIAID director Anthony Fauci. This rapid response, getting a vaccine into phase I trials within three months of the sequencing of the virus, is a new record. Yourway has extensive experience in supporting accelerated clinical trials when the need is acute.

Back to Index

Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Schedule a Meeting

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Schedule a Meeting

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat

Hello! How can I help you?